

Integra LifeSciences Holdings Corporation (NASDAQ:IART) completed a $2.1 billion refinancing on October 19, 2026. Its revolving credit commitment fell $700...
You can purchase shares of Integra Lifesciences (NASDAQ:IART) through any online brokerage.
Other companies in Integra Lifesciences’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Integra Lifesciences has a consensus price target of $20.43.
The stock price for Integra Lifesciences (NASDAQ: IART) is $12.83 last updated October 29, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Integra Lifesciences.
Integra Lifesciences does not have any upcoming earnings scheduled.
There is no upcoming split for Integra Lifesciences.
Integra Lifesciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman...